Cell Culture Market Growth – at a CAGR of 10.3% During Forecast Period 2019-2027
Increasing demand for personalized medicines, improving healthcare and research infrastructure, and rising awareness about cell culture based products are some key factors expected to drive market revenue growth
Emergen Research has published its latest report titled, “Cell Culture Market Size, Share, Trends, By Consumables (Media, Sera, Reagents), By Product (Culture Systems, Incubators, Centrifuges, Pipetting Instruments, Biosafety Equipment, Cryostorage Equipment), By Application, and By Region Forecasts to 2027”
According to Emergen Research, the global cell culture market size was USD 20.52 billion in 2019 and is expected to reach USD 45.12 billion in 2027 and register a revenue CAGR of 10.3% during the forecast period, 2020-2027.
Cell culture is a process in which cells isolated from living tissues are grown under a controlled environment outside their natural habitat. These cells are isolated from tissues and inoculated in sterile petri dishes and flasks, under optimum conditions to avoid contamination. The culture conditions vary from cell to cell type but commonly comprise substrate or medium with essential nutrients such as carbohydrates, amino acids, minerals, hormones, growth factors, and gases, under optimum temperature, humidity. However, high usage of plastic consumables and increasing preference for single-use bioprocessing systems is adversely affecting the environment.
Over the recent years, there has been a rapid increase in the investments and funding for cell-based research due to rising incidence of cancer and cardiovascular diseases worldwide. Factors such as increasing adoption of advanced cell culture techniques, rising demand for monoclonal antibodies, and increasing awareness about cell culture techniques and benefits of cell-based vaccines are expected to drive global market revenue growth during the forecast period. Other factors such as increasing healthcare spending, rising number of pharmaceutical and biotechnology companies in many countries across the globe, and high focus on cancer research, drug development, and vaccine production are expected to fuel market revenue growth going ahead. However, ethical issues about use of animal-derived products, unavailability of skilled healthcare professionals in certain developing economies, and high costs of cell biology research are some key factors that can restrain overall market growth during the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Media Segment to Register Significant Revenue Growth:
The media segment is expected to register a significant revenue growth over the forecast period owing to increasing cell culture research-based activities, high preference for various medias due to low prices as compared to sera and high demand for culturing in cytology related projects.
Cell Culture Systems Segment to Account for Largest Revenue Share:
The cell culture systems accounted for largest revenue share between 2020 and 2027 owing to improving healthcare and research facilities, rising healthcare infrastructure, introduction of technologically advanced cell culture systems, and increasing R&D investments.
North America to Lead In Terms of Revenue:
North America is expected to dominate other regional markets in terms of revenue over the forecast period owing to rising prevalence of chronic diseases, rapid technological advancements, and increasing investments in cell-based research. In addition, presence of well-developed healthcare infrastructure and research facilities, high healthcare spending, rapidly expanding pharmaceutical and biotechnology industries, and favorable regulatory approvals for cell culture-based vaccines are expected to fuel North America market growth during the forecast period.
Major Companies in the Market Include:
- Thermo Fisher Scientific Inc.
- Cell Culture Company LLC
- Sigma-Aldrich Co. LLC
- Corning Incorporated
- Dickinson & Company
- VWR International LLC
- BioSpherix Ltd.
- General Electric
- Sartorius AG
- Merck KGaA
For the purpose of this report, Emergen Research has segmented the global cell culture market on the basis of consumables, product, application, and region:
Consumables Outlook (Revenue, USD Billion; 2017-2027)
Product Outlook (Revenue, USD Billion; 2017-2027)
- Culture Systems
- Pipetting Instruments
- Biosafety Equipment
- Cryostorage Equipment
Application Outlook (Revenue, USD Billion; 2017-2027)
- Cancer Research
- Vaccine Production
- Drug Development
- Gene Therapy
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
The Global Medical Supplies Market size was valued at USD 126.57 Billion in 2019 and is anticipated to reach USD 180.89 Billion by 2027 at a CAGR of 4.5%. A rapid increase in chronic diseases due to the unhealthy lifestyle is a major factor propelling the demand for the medical supplies market.
The Global Industrial Microbiology Market size was valued at USD 10.80 Billion in 2019 and is expected to reach USD 17.71 Billion by 2027 at a CAGR of 6.8%. The global industrial microbiology market is anticipated to grow exponentially over the forecasted timeline due to the rising demand for microbial applications and vaccines' development.
The Global Blockchain in Genomics Market size was valued at USD 24.5 Million in 2019 and is anticipated to reach USD 1,258.3 Million by 2027 at a CAGR of 65.8%. The global market for blockchain in genomics is likely to grow significantly, owing to the increasing demand for data security of unique genomic data.
The global nanopharmaceutical drugs market size was valued at USD 46.90 Billion in 2019 and is forecasted to reach USD 82.71 Billion by 2027 at a CAGR of 7.3%. The nanopharmaceutical drugs market is observing high demand attributed to its increasing application in oncology, cardiovascular/physiology, anti-inflammatory/immunology, neurology, and anti-biotic.
The global clinical perinatal software market size was valued at USD 212.6 Million in 2019 and is forecasted to reach USD 393.3 Million by 2027 at a CAGR of 7.9%. The clinical perinatal software market is observing high demand attributed to its increasing application in workflow management, fetal monitor data services, and patient documentation.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Visit for More Insights: https://www.emergenresearch.com/insights
Read Our Press release@ https://www.emergenresearch.com/press-release/global-cell-culture-market